Current Topics in Medicinal Chemistry

Editor-in-Chief

Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
(USA)

Back

Become EABM
Become Reviewer



Editorial: Current Approaches in the Treatment of Neuropsychiatric Diseases free to download

Volume:16   Issue: 29
Pp: 3383-3384
Peng Li
DOI: 10.2174/156802661629161020221913



Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future open access plus

Volume:16   Issue: 29
Pp: 3385-3403
Peng Li, Gretchen L. Snyder and Kimberly E. Vanover
DOI: 10.2174/1568026616666160608084834




Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders

Volume:16   Issue: 29
Pp: 3404-3437
Christopher L. Cioffi and Peter R. Guzzo
DOI: 10.2174/1568026616666160405113340




Orexin Receptor Antagonists: Historical Perspectives and Future Opportunities

Volume:16   Issue: 29
Pp: 3438-3469
Stephen P. Andrews, Sarah J. Aves, John A. Christopher and Rebecca Nonoo
DOI: 10.2174/1568026616666150929111607




Enhancing cAMP Levels as Strategy for the Treatment of Neuropsychiatric Disorders

Volume:16   Issue: 29
Pp: 3527-3535
Ana M. Garcia, Ana Martinez and Carmen Gil
DOI: 10.2174/1568026616666160426151306




AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders

Volume:16   Issue: 29
Pp: 3536-3565
Tristan Reuillon, Simon E. Ward and Paul Beswick
DOI: 10.2174/1568026616666160627114507